Matches in SemOpenAlex for { <https://semopenalex.org/work/W248764848> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W248764848 endingPage "38" @default.
- W248764848 startingPage "2327" @default.
- W248764848 abstract "Combinations of nucleoside analog drugs, such as F-araA and ara-C, combined with Topoisomerase II inhibitors, such as anthracyclines, are synergistic against human leukemic T-cells and induce apoptotic cell death. Similarly, nucleoside analog drugs followed by mitotic inhibitors also have a synergistic effect. Sequence specific combinations of F-araA followed by ara-C and Taxotere (docetaxel) in CEM/0 cells showed a 2- to 3-fold synergism over the two drug (F-araA + ara-C) combinations and 2- to 4-fold synergism over Taxotere alone. This synergism was evident due to enhanced cellular apoptosis. In the CEM/ara-C/7A cell line, which is partially resistant to ara-C, the synergy observed with the triple drug combination was 9-fold greater than the F-araA plus araC combination, and 3-fold greater than Taxotere alone, making this three-drug regimen collaterally sensitive to ara-C. This study describes the mechanisms of the synergistic effect in regards to apoptosis achieved by three-drug regimens comprised of two nucleoside analog drugs and a mitotic inhibitor in comparison with the combination of two nucleotide analog drugs. The study also demonstrates that the possible biochemical mechanism of cellular toxicity and drug synergism is attributed to induction of apoptosis following drug treatment and the onset of the apoptotic cascade is primarily regulated by p21/WAF-I, which is transcriptionally activated by p53 following DNA damage. The anti-apoptotic protein, bcl-2, seemed to have no effect in inhibiting apoptosis following treatment with the two or three drug regimens in this in vitro leukemia model. The three-drug combination induced greater cellular apoptosis than the two-drug combination or Taxotere monotherapy. We conclude that the greater drug synergism observed in human leukemic cells, sensitive or resistant to ara-C, by Fludarabine + ara-C + Taxotere can be explained by the greater oligonucleosomal DNA fragmentation indicative of increased cellular apoptosis. The mechanism of this increased cytotoxic action is due to the upregulation of p53 and p21/WAF-1 with a down regulation of bcl-2. These studies are encouraging, and testing this three drug regimen in a clinical setting may result in improved antileukemic therapies." @default.
- W248764848 created "2016-06-24" @default.
- W248764848 creator A5025288612 @default.
- W248764848 creator A5054535169 @default.
- W248764848 creator A5054897680 @default.
- W248764848 creator A5056302309 @default.
- W248764848 creator A5058573134 @default.
- W248764848 creator A5079421911 @default.
- W248764848 creator A5085527662 @default.
- W248764848 date "1998-08-15" @default.
- W248764848 modified "2023-09-23" @default.
- W248764848 title "Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells." @default.
- W248764848 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9703875" @default.
- W248764848 hasPublicationYear "1998" @default.
- W248764848 type Work @default.
- W248764848 sameAs 248764848 @default.
- W248764848 citedByCount "14" @default.
- W248764848 countsByYear W2487648482013 @default.
- W248764848 countsByYear W2487648482014 @default.
- W248764848 countsByYear W2487648482015 @default.
- W248764848 crossrefType "journal-article" @default.
- W248764848 hasAuthorship W248764848A5025288612 @default.
- W248764848 hasAuthorship W248764848A5054535169 @default.
- W248764848 hasAuthorship W248764848A5054897680 @default.
- W248764848 hasAuthorship W248764848A5056302309 @default.
- W248764848 hasAuthorship W248764848A5058573134 @default.
- W248764848 hasAuthorship W248764848A5079421911 @default.
- W248764848 hasAuthorship W248764848A5085527662 @default.
- W248764848 hasConcept C190283241 @default.
- W248764848 hasConcept C203014093 @default.
- W248764848 hasConcept C2776543447 @default.
- W248764848 hasConcept C2776694085 @default.
- W248764848 hasConcept C2776755627 @default.
- W248764848 hasConcept C2777333352 @default.
- W248764848 hasConcept C2778041864 @default.
- W248764848 hasConcept C2778119113 @default.
- W248764848 hasConcept C2778461978 @default.
- W248764848 hasConcept C2779263901 @default.
- W248764848 hasConcept C2780500152 @default.
- W248764848 hasConcept C2781190966 @default.
- W248764848 hasConcept C31573885 @default.
- W248764848 hasConcept C502942594 @default.
- W248764848 hasConcept C54355233 @default.
- W248764848 hasConcept C55493867 @default.
- W248764848 hasConcept C86803240 @default.
- W248764848 hasConcept C98274493 @default.
- W248764848 hasConceptScore W248764848C190283241 @default.
- W248764848 hasConceptScore W248764848C203014093 @default.
- W248764848 hasConceptScore W248764848C2776543447 @default.
- W248764848 hasConceptScore W248764848C2776694085 @default.
- W248764848 hasConceptScore W248764848C2776755627 @default.
- W248764848 hasConceptScore W248764848C2777333352 @default.
- W248764848 hasConceptScore W248764848C2778041864 @default.
- W248764848 hasConceptScore W248764848C2778119113 @default.
- W248764848 hasConceptScore W248764848C2778461978 @default.
- W248764848 hasConceptScore W248764848C2779263901 @default.
- W248764848 hasConceptScore W248764848C2780500152 @default.
- W248764848 hasConceptScore W248764848C2781190966 @default.
- W248764848 hasConceptScore W248764848C31573885 @default.
- W248764848 hasConceptScore W248764848C502942594 @default.
- W248764848 hasConceptScore W248764848C54355233 @default.
- W248764848 hasConceptScore W248764848C55493867 @default.
- W248764848 hasConceptScore W248764848C86803240 @default.
- W248764848 hasConceptScore W248764848C98274493 @default.
- W248764848 hasIssue "4A" @default.
- W248764848 hasLocation W2487648481 @default.
- W248764848 hasOpenAccess W248764848 @default.
- W248764848 hasPrimaryLocation W2487648481 @default.
- W248764848 hasRelatedWork W137194026 @default.
- W248764848 hasRelatedWork W1596537940 @default.
- W248764848 hasRelatedWork W1978805491 @default.
- W248764848 hasRelatedWork W1996292378 @default.
- W248764848 hasRelatedWork W2105906645 @default.
- W248764848 hasRelatedWork W2167754796 @default.
- W248764848 hasRelatedWork W2397265158 @default.
- W248764848 hasRelatedWork W248764848 @default.
- W248764848 hasRelatedWork W3208459517 @default.
- W248764848 hasRelatedWork W3208765402 @default.
- W248764848 hasVolume "18" @default.
- W248764848 isParatext "false" @default.
- W248764848 isRetracted "false" @default.
- W248764848 magId "248764848" @default.
- W248764848 workType "article" @default.